Crescent City Ear, Nose and Throat is categorized under Ear Nose and Throat Doctors in Marrero, LA and active since 2013.
Crescent City Ear, Nose and Throat was established in 2013, and today employs 1 to 4, earning Unknown per year. This is a Ear Nose and Throat Doctors business, which does work in the B2C market, and is classified as a Ear Nose and Throat Doctors, under code number by the NAICS.
If you are seeking more information, feel free to contact Charles Ballay at the company’s single location by writing to 1111 Medical Center Blvd., 707 North, Marrero, Louisiana LA 70072 or by phoning (504) 934-8550. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Crescent City Ear, Nose and Throat |
| Contact Person: | Charles Ballay |
| Address: | 1111 Medical Center Blvd., 707 North, Marrero, Louisiana 70072 |
| Phone Number: | (504) 934-8550 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ear Nose and Throat Doctors |
| Share This Business: |
Crescent City Ear, Nose and Throat was started in 2013 to provide professional Ear Nose and Throat Doctors under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Charles Ballay for inquiries that concern Crescent City Ear, Nose and Throat by calling the company number (504) 934-8550, as your correspondence is most welcome. Additionally, the physical location of the single location of Crescent City Ear, Nose and Throat can be found at the coordinates 29.891333,-90.0958176 as well as the street address 1111 Medical Center Blvd., 707 North in Marrero, Louisiana 70072.
For its online presence, you may visit Crescent City Ear, Nose and Throat’s website at and engage with its social media outlets through on Twitter and on Facebook.